QUINTILES IMS HOLDINGS, INC. (NYSE:Q) Files An 8-K Results of Operations and Financial ConditionItem 2.02 Results of Operations and Financial Condition.
See the Exhibit Index attached hereto.
Quintiles IMS Holdings, Inc. ExhibitEX-99 2 a51621535ex99_1.htm EXHIBIT 99.1 Exhibit 99.1 QuintilesIMS Reports Second-Quarter 2017 Results GAAP Revenue $1,…To view the full exhibit click here
About QUINTILES IMS HOLDINGS, INC. (NYSE:Q)
Quintiles IMS Holdings Inc, formerly Quintiles Transnational Holdings Inc., is a provider of biopharmaceutical development services and commercial outsourcing services. It is engaged in the development and commercialization of pharmaceutical therapies. Its segments include Product Development and Integrated Healthcare Services. Its Product Development segment is a contract research organization and is focused on Phase II-IV clinical trials and associated laboratory and analytical activities. The Integrated Healthcare Services segment includes commercial pharmaceutical sales and service organizations, and provides services, including commercial services, such as contract pharmaceutical sales forces, and healthcare business services for the healthcare sector, such as phase research, market access and consulting, health information analytics and technology consulting, and other healthcare solutions.
